Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-09-023228
Filing Date
2009-07-17
Accepted
2009-07-17 17:12:42
Documents
12

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. - FORM S-1/A c0628619sv1za.htm S-1/A 2208060
2 EX-3.1 THIRD AMENDED AND RESTATED CHARTER OF CUMBERLAND PHARMACEUTICALS INC. c0628619exv3w1.htm EX-3.1 40531
3 EX-3.2 SECOND AMENDED AND RESTATED BYLAWS OF CUMBERLAND PHARMACEUTICALS INC. c0628619exv3w2.htm EX-3.2 54361
4 EX-10.13.1 EMPLOYMENT AGREEMENT - LEO PAVLIV c0628619exv10w13w1.htm EX-10.13.1 5509
5 EX-10.26 EMPLOYMENT AGREEMENT - MARTIN E. CEARNAL c0628619exv10w26.htm EX-10.26 21512
6 EX-23.1 CONSENT OF KPMG LLP. c0628619exv23w1.htm EX-23.1 2727
7 GRAPHIC c0628619c0628602.gif GRAPHIC 3768
8 GRAPHIC c0628619c0628643.gif GRAPHIC 6950
9 GRAPHIC c0628619c0628644.gif GRAPHIC 6473
10 GRAPHIC c0628619c0628645.gif GRAPHIC 8587
11 GRAPHIC c0628619c0628600.gif GRAPHIC 5123
12 GRAPHIC c0628619c0628610.gif GRAPHIC 337
  Complete submission text file 0000950123-09-023228.txt   2378025
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 09951437
SIC: 2834 Pharmaceutical Preparations